Rhythm Pharmaceuticals (RYTM) Times Interest Earned (2022 - 2026)
Rhythm Pharmaceuticals (RYTM) reported Times Interest Earned of -$11.43 for Q1 2026, down 31.47% year-over-year from -$16.67 in Q1 2025, and down 12.03% quarter-over-quarter from -$10.2 in Q4 2025.
Rhythm Pharmaceuticals (RYTM) Times Interest Earned (2022 - 2026) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has 5 years of Times Interest Earned data on file, last reported at -$11.43 in Q1 2026.
- Times Interest Earned for Q1 2026 came in at -$11.43, down 31.47% year-over-year; the trailing twelve-month figure through Mar 2026 was -$9.99 (down 19.8% YoY), and the FY2025 annual result was -$9.33, up 27.61% from the prior year.
- Times Interest Earned declined to -$11.43 in Q1 2026 per RYTM's latest filing, from -$10.2 in the prior quarter.
- Over five years, Times Interest Earned peaked at -$7.57 in Q4 2024 and troughed at -$980.35 in Q2 2022.
- A 5-year average of -$73.14 and a median of -$11.26 in 2025 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2023 and 2024: Times Interest Earned jumped 98.56% in 2023, then plunged 71.43% in 2024.
- A 5-year view of Times Interest Earned shows it stood at -$13.98 in 2022, then soared by 35.14% to -$9.07 in 2023, then gained by 16.49% to -$7.57 in 2024, then sank by 34.64% to -$10.2 in 2025, then fell by 12.03% to -$11.43 in 2026.
- Business Quant data shows RYTM's Times Interest Earned at -$11.43 in Q1 2026, -$10.2 in Q4 2025, and -$11.1 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Rhythm Pharmaceuticals | 6.59 Bn | 6.25 Bn | 52.96 Mn | -11.43 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.43 |
| Dec 31, 2025 | -10.20 |
| Sep 30, 2025 | -11.10 |
| Jun 30, 2025 | -7.79 |
| Mar 31, 2025 | -8.69 |
| Dec 31, 2024 | -7.57 |
| Sep 30, 2024 | -8.37 |
| Jun 30, 2024 | -8.79 |
| Mar 31, 2024 | -29.42 |
| Dec 31, 2023 | -9.07 |
| Sep 30, 2023 | -13.96 |
| Jun 30, 2023 | -14.11 |
| Mar 31, 2023 | -17.16 |
| Dec 31, 2022 | -13.98 |
| Sep 30, 2022 | -18.31 |
| Jun 30, 2022 | -980.35 |